Innovative pharmaceuticals: cutting-edge medicines under development in BRICS countries
Russian companies are ramping up production of medicines for cancer and autoimmune diseases. The domestic bioeconomy is already worth US$2 billion. Other BRICS countries are also actively developing this sector.
What medicines, with no equivalents anywhere in the world, are being produced in BRICS?
Details in our report.
TV BRICS reporter: Ekaterina Fomina
TV BRICS cameraman: Daniil Amangulov
We would like to thank the company “R-Pharm” for their assistance with the filming.
Translated and voiced by Artificial Intelligence.
DIGITAL WORLD
BRICS+ Media Centre
MODERN RUSSIAN